Enanta Pharmaceuticals, Inc. (ENTA) was a big mover last session with its shares rising nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company, as the stock is now up over 20% in the past one-month time frame.

This biotechnology company has seen one positive estimate revision in the last 60 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can turn into more strength down the road.

Enanta Pharmaceuticals currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is negative.

Investors interested in the Med-Drugs industry may also consider stocks like Lannett Company, Inc. (LCI), Cempra, Inc. (CEMP) and Mallinckrodt plc (MNK). While Lannett and Cempra sport a Zacks Rank #1 (Strong Buy), Mallinckrodt carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ENANTA PHARMACEUTICALS INC (ENTA): Free Stock Analysis Report

LANNETT COMP (LCI): Free Stock Analysis Report

CEMPRA INC (CEMP): Free Stock Analysis Report

MALLINCKRODT PUBLIC LTD CO (MNK): Free Stock Analysis Report


Zacks Investment Research